GIP
EW icon

Granite Investment Partners’s Edwards Lifesciences EW Stock Holding History

Granite Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-726
Closed -$34K – 320
2018
Q1 		$34K Buy
+726
New +$31.5K ﹤0.01% 296

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Granite Investment Partners's EW Position: Q2 2018 in Review

Granite Investment Partners sold out of Edwards Lifesciences (EW) in Q2 2018, closing a stake of 726 shares — an estimated $34K sold.

Granite Investment Partners first reported a position in EW in Q1 2018 and held it in 1 quarter. The position peaked at $34K in Q1 2018. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

  • Granite Investment Partners reported no remaining Edwards Lifesciences position as of Q2 2018 after selling out during the quarter.
  • Granite Investment Partners sold 726 Edwards Lifesciences shares in Q2 2018, an estimated $34K.
  • Granite Investment Partners first reported a position in Edwards Lifesciences in Q1 2018 and held it in 1 quarter.
  • Granite Investment Partners's Edwards Lifesciences position peaked at $34K in Q1 2018.
  • 838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on Granite Investment Partners's 13F filing for Q2 2018, filed 6 Aug 2018.